Skip to content
‹ Back to IndustriesSciences

Why You Shouldn’t Be Using ‘Conventional’ Methods for Unconventional Drilling

The Sciences Podcast explores the use of big data for both conventional and unconventional reservoirs with insights from geoscientists at Ikon Science. Gabi D’Aubeterre and Yoryenys Del Moro discuss the challenges of unconventional reservoirs, highlighting the need for advanced data techniques. Unconventional drilling requires changing traditional methods to effectively extract hydrocarbons.

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · · DrillingGabi D’aubeterre PodcastGeopredictionGeoscientist
Share
Why You Shouldn’t Be Using ‘Conventional’ Methods for Unconventional Drilling

Key takeaways

01

Ikon Science experts emphasize the necessity to change traditional methods when dealing with unconventional reservoirs.

02

Big data including seismic and well information is crucial for optimizing production in unconventional drilling.

03

Unconventional reservoirs require advanced techniques to effectively extract hydrocarbons, as traditional trapping mechanisms are absent.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

On this episode of the Sciences Podcast, host Tyler Kern dug deep, so to speak, on the topic of using big data for conventional and unconventional reservoirs with two geoscientists from Ikon Science. Today’s guests are Gabi D’Aubeterre], Americas support team manager, and Yoryenys Del Moro, regional product champion for wells.

Del Moro said current methods are just scratching the surface of what kind of production is possible.

“To get more production, … we need to use more data, including seismic and well information,” she said.

Ikon Science develops pioneering GeoPrediction software technology and solutions to help customers have better hit rates and faster production with reduced cost and cycle time. The quantitative interpretation of seismic and well data has been widely successful for conventional operations around the world but lags in unconventional reservoirs, D’Aubeterre and Del Moro said.

“When it comes to unconventional reservoirs, we need to change our mindset from what we’ve done traditionally,” D’Aubeterre said.

Unconventional reservoirs pose a unique challenge for geoscientists. While the rocks in conventional reservoirs effectively traps oil and gas until it’s drilled, this same trapping mechanism is not present in more difficult unconventional plays. In a conventional reservoir, the type of rock (usually a sandstone) traps the hydrocarbon effectively within its porous space, but this is not the case for unconventional reservoirs.

“In an unconventional reservoir, the hydrocarbons do not flow naturally and are trapped within the rock, within low permeability and low porosity units” D’Aubeterre said. Fracturing the rock and shale to extract that oil and gas makes a challenge for geoscientists and engineers.

Del Moro agreed, saying complications exist when geoscientists and engineers look to fracture the right area of rock for the right natural resource to produce hydrocarbons.

“So you need to apply the techniques that allow you to define and detect what you’re looking for in the shales, fractures, and natural fracture zones,” Del Moro said, explaining seismic data allows you to do that.

D’Aubeterre and Del Moro shared specific examples of quantitative interpretation of seismic and well data in unique settings and how the machine learning and integration.

Read more on the Ikon Science Website.

Follow us on social media for the latest updates in B2B!

Twitter – twitter.com/ScienceMKSL

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Why shared auto-injectors keep forcing rebuilt device files

Why shared auto-injectors keep forcing rebuilt device files

Vertex Knight co-founder Fubin Wu cites digitalization, personalization and large-volume delivery as trends reshaping drug delivery devices, arguing structured data can enable reuse and cut duplicated design-file work for shared auto-injectors. ISPE says no regulatory pathway exists for platform devices, and ONdrugDelivery counts 182 large-volume subcutaneous biologics, about 15% of IV and SC agents.

  • 01A device shared across drug products still triggers repeated design control work for each new combination product, and ISPE's November 2025 article says no regulatory pathway yet exists to approve a platform device.
  • 02FDA's May 2024 draft platform technology designation under section 506K is written for drug product applications, so device design files sit outside it.
  • 03Large-volume subcutaneous biologics above 2 mL numbered 182 in a January 2025 ONdrugDelivery review, about 15% of IV and SC agents; Advanced Drug Delivery Reviews reported in July 2026 that volumes up to 25 mL are now pursued.

Oct 22, 2026

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's FOYA-winning syringe plant inspects 24,000 units an hour

Hepalink's Pingshan prefilled syringe plant in Shenzhen won the Innovation (Novel Technology) category at ISPE's 2026 Facility of the Year Awards. In the transcript ISPE posted with its podcast, CaiXue Wei describes vertical design, AGV-assisted transfer, AI inspection and 5G-MEC as one integrated system built around a 330 million-syringe annual capacity; Hepalink's own release adds a 24-meter warehouse, sub-10 millisecond 5G and 24,000-unit-an-hour inspection.

  • 01Hepalink's 24-meter automated warehouse raised space utilization 52 percent over a traditional layout on a land-scarce Shenzhen site supporting 330 million syringes a year.
  • 02AGVs pass material through vaporized hydrogen peroxide chambers straight into Grade A isolators, and Hepalink credits the zero-touch flow for a 100 percent first media fill.

Oct 22, 2026

Chalmers' AI scientist turned 60,000 yeast records into nearly 2,000 testable ideas

Chalmers' AI scientist turned 60,000 yeast records into nearly 2,000 testable ideas

Chalmers University of Technology's AI scientist Eve analyzed about 60,000 public yeast records, came up with almost 2,000 testable ideas, and took full charge of planning the experiments and telling other robots what to do, according to CORDIS. Humans handled safety checks and plate moving.

  • 01The key step for company labs is translation: turning hypotheses into machine-executable protocols and getting contextualized results back to the reasoning layer fast.

Oct 19, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Experts

S
Sciences
GD
Gabi D’Aubeterre

Americas Support Team Manager

Ikon Science

YD
Yoryenys Del Moro

Regional Product Champion for Wells

Ikon Science

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512